The global hyperbaric oxygen therapy treatment market was valued at $275.1 million in 2021, and is estimated to reach $457.64 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031.
Hyperbaric medicine is a pressure environment larger than the atmospheric pressure at sea level. In hyperbaric oxygen therapy (HBOT), 100% oxygen is breathed in, which is carried out at elevated atmospheric pressure. A specific room or tiny chamber is used for hyperbaric oxygen therapy (HBOT), which entails breathing practically pure oxygen. For many years, severe anaemia and other medical disorders have been treated with hyperbaric oxygen therapy.
The major factors that drive the growth of the hyperbaric oxygen therapy treatment market include increase in utilization for wound healing, decompression sickness, gas embolism and awareness regarding the therapy. HBOT is also used to cure a variety of illnesses, including life-threatening crises, including aesthetic operations, wound healing, gas embolism, radiation tissue damage (ORN), and refractory osteomyelitis, due to advancements in technology. Emerging markets possess high growth potential due to availability of improved healthcare infrastructure, unmet healthcare needs, and rise in incidence of diabetes. Furthermore, the developing countries such as China and India present lucrative opportunities for key players that operate in the hyperbaric oxygen therapy market, owing to presence of high population base, increase in awareness about advanced wound care, and rise in demand for advanced therapies. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, due to upsurge in demand for advanced healthcare services, significant investments by governments of developing countries to improve the healthcare infrastructure, and development of the medical tourism industry in emerging countries. These factors are projected to create remunerative opportunities for market expansion during the forecast period.
Adventurous activities like scuba diving or deep-sea diving cause decompression sickness which can be successfully treated using hyperbaric oxygen therapy. In addition, rise in diabetic population drives the market growth as diabetic foot ulcers and wounds can be treated up to greater extent using hyperbaric oxygen therapy.
Furthermore, growth potential due to availability of improved healthcare infrastructure, unmet healthcare needs, and rise in incidence of diabetes & obesity in developing economies is a lucrative opportunity for the market growth. Conversely, reimbursement for oxygen therapy is a tough challenge and complications post therapy are expected to hinder the market growth.
The hyperbaric oxygen therapy treatment market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is categorized into monoplace chamber, multiplace chamber and others. By application, it is divided into wound healing, decompression sickness and others. The wound healing segment is further bifurcated into chronic wounds and acute wounds. By end user, it is segmented into hospitals, home care and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Environmental Tectonics Corporation, Fink Engineering Pty Ltd, Gulf Coast Hyperbarics Inc., GWR Medical Inc, Haux-Life-Support GmbH, HearMec Co, Hipertech Electronics Inc, Hyperbaric Modular Systems, Inc, Hyperbaric SAC, OxyHealth Llc, Pan-America Hyperbarics Inc, Perry Baromedical Corporation, Richmond Hyperbaric Health Centre Inc, Royal IHC, Sechrist Industries, Inc., Tekna Hyperbaric Chambers, and Unique Group FZC.
Hyperbaric medicine is a pressure environment larger than the atmospheric pressure at sea level. In hyperbaric oxygen therapy (HBOT), 100% oxygen is breathed in, which is carried out at elevated atmospheric pressure. A specific room or tiny chamber is used for hyperbaric oxygen therapy (HBOT), which entails breathing practically pure oxygen. For many years, severe anaemia and other medical disorders have been treated with hyperbaric oxygen therapy.
The major factors that drive the growth of the hyperbaric oxygen therapy treatment market include increase in utilization for wound healing, decompression sickness, gas embolism and awareness regarding the therapy. HBOT is also used to cure a variety of illnesses, including life-threatening crises, including aesthetic operations, wound healing, gas embolism, radiation tissue damage (ORN), and refractory osteomyelitis, due to advancements in technology. Emerging markets possess high growth potential due to availability of improved healthcare infrastructure, unmet healthcare needs, and rise in incidence of diabetes. Furthermore, the developing countries such as China and India present lucrative opportunities for key players that operate in the hyperbaric oxygen therapy market, owing to presence of high population base, increase in awareness about advanced wound care, and rise in demand for advanced therapies. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, due to upsurge in demand for advanced healthcare services, significant investments by governments of developing countries to improve the healthcare infrastructure, and development of the medical tourism industry in emerging countries. These factors are projected to create remunerative opportunities for market expansion during the forecast period.
Adventurous activities like scuba diving or deep-sea diving cause decompression sickness which can be successfully treated using hyperbaric oxygen therapy. In addition, rise in diabetic population drives the market growth as diabetic foot ulcers and wounds can be treated up to greater extent using hyperbaric oxygen therapy.
Furthermore, growth potential due to availability of improved healthcare infrastructure, unmet healthcare needs, and rise in incidence of diabetes & obesity in developing economies is a lucrative opportunity for the market growth. Conversely, reimbursement for oxygen therapy is a tough challenge and complications post therapy are expected to hinder the market growth.
The hyperbaric oxygen therapy treatment market is segmented on the basis of type, application, end user, and region. On the basis of type, the market is categorized into monoplace chamber, multiplace chamber and others. By application, it is divided into wound healing, decompression sickness and others. The wound healing segment is further bifurcated into chronic wounds and acute wounds. By end user, it is segmented into hospitals, home care and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Environmental Tectonics Corporation, Fink Engineering Pty Ltd, Gulf Coast Hyperbarics Inc., GWR Medical Inc, Haux-Life-Support GmbH, HearMec Co, Hipertech Electronics Inc, Hyperbaric Modular Systems, Inc, Hyperbaric SAC, OxyHealth Llc, Pan-America Hyperbarics Inc, Perry Baromedical Corporation, Richmond Hyperbaric Health Centre Inc, Royal IHC, Sechrist Industries, Inc., Tekna Hyperbaric Chambers, and Unique Group FZC.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hyperbaric oxygen therapy market analysis from 2021 to 2031 to identify the prevailing hyperbaric oxygen therapy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the hyperbaric oxygen therapy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global hyperbaric oxygen therapy market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Monoplace Chambers
- Multiplace Chambers
- Others
By Application
- Wound Healing
- Type
- Chronic Wounds
- Acute Wounds
- Decompression Sickness
- Others
By End User
- Hospitals
- Home Care
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Airox Technologies Limited
- Environmental Tectonics Corporation (ETC)
- Fink Engineering Pty Ltd
- Gulf Coast Hyperbarics Inc
- Haux-Life-Support GmbH
- HearMec Co
- Hipertech Electronics Inc.
- Hyperbaric Modular Systems, Inc.
- Hyperbaric SAC
- Pan-America Hyperbarics Inc
- Perry Baromedical Corporation
- Richmond Hyperbaric Health Centre Inc
- Royal IHC
- Sechrist Industries, Inc
- SOS Group
- Tekna Hyperbaric Chambers
- Unique Group FZC
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Patent Landscape
CHAPTER 4: HYPERBARIC OXYGEN THERAPY MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Monoplace Chambers
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Multiplace Chambers
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: HYPERBARIC OXYGEN THERAPY MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Wound Healing
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Wound Healing Hyperbaric Oxygen Therapy Market by Type
5.2.4.1 Chronic Wounds Market size and forecast, by region
5.2.4.2 Acute Wounds Market size and forecast, by region
5.3 Decompression Sickness
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: HYPERBARIC OXYGEN THERAPY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Home Care
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: HYPERBARIC OXYGEN THERAPY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America Wound Healing Hyperbaric Oxygen Therapy Market by Type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe Wound Healing Hyperbaric Oxygen Therapy Market by Type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific Wound Healing Hyperbaric Oxygen Therapy Market by Type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA Wound Healing Hyperbaric Oxygen Therapy Market by Type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Airox Technologies Limited
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Environmental Tectonics Corporation (ETC)
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Fink Engineering Pty Ltd
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Gulf Coast Hyperbarics Inc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Haux-Life-Support GmbH
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 HearMec Co
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Hipertech Electronics Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Hyperbaric Modular Systems, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Hyperbaric SAC
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Pan-America Hyperbarics Inc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Perry Baromedical Corporation
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Richmond Hyperbaric Health Centre Inc
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Royal IHC
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Sechrist Industries, Inc
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 SOS Group
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Tekna Hyperbaric Chambers
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Unique Group FZC
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Hyperbaric Oxygen Therapy Market,' the hyperbaric oxygen therapy market was valued at $275.10 million in 2021, and is estimated to reach $457.6 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031.Hyperbaric oxygen therapy is carried out in close chamber in which person breathes in pure oxygen. It is used to treat various diseases like gangrene, decompression sickness, infections, carbon monoxide poisoning, stubborn wounds, and diabetic foot ulcers. About 2.5 times more air is compressed inside a hyperbaric oxygen chamber than normal atmospheric pressure. The lungs can absorb a lot more oxygen in these circumstances than they could if one were inhaling pure oxygen at standard air pressure.
The FDA has approved the use of hyperbaric oxygen therapy (HBOT) for the treatment of non-healing lesions, such as diabetic foot ulcers. Increase in prevalence of diabetes is a major factor that drives the market growth. In addition, increase in adventurous activities is one of the upcoming hyperbaric oxygen therapy market trends. Decompression sickness is frequently reported during adventurous activities and is effectively treated with hyperbaric oxygen therapy.
The hyperbaric oxygen therapy market is experiencing growth owing to advancement in technology. New technologies are causing changes in every sector of the economy. Hyperbaric oxygen treatment can now be used to treat a variety of illnesses owing to increase in technological advancements. In contrast, rise in health care expenditure and increase in the burden of diabetes present a tremendous investment potential for key players, particularly in developing nations. In addition, the expansion of the industry is fueled by opportunities in emerging markets.
By type, the market is segmented into monoplace chambers, multiplace chambers and others. The monoplace chambers segment generated maximum revenue in 2021, and also witnessed highest CAGR during the forecast period, as monoplace chambers are more comfortable and less confining than multiplace chambers. By application, the market is divided into decompression sickness, wound healing and others. The wound healing segment dominated the market in 2021, and is expected to witness highest CAGR during the forecast period owing to increase in incidence of wounds and effective treatment for chronic wounds & diabetic foot ulcers.
By end user, the market is divided into hospitals, home care and others. The others segment dominated the hyperbaric oxygen therapy market size in 2021, owing to increase in demand for standalone hyperbaric oxygen therapy centers and increase in usage of hyperbaric oxygen chambers in clinics. The home care segment is expected to witness highest CAGR during the forecast period owing to increase in demand for personalized health care.
By region, North America accounted for a majority of the global hyperbaric oxygen therapy market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in hyperbaric oxygen therapy treatment techniques, integration of advanced devices and software processes in hyperbaric oxygen therapy, and presence of robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable hyperbaric oxygen therapy market growth, owing rise in diabetic population, development of healthcare infrastructure and increase in investment projects in the region.
Key findings of the study
- By type, the monoplace chambers segment was the highest contributor to the HBOT market in 2021.
- By application, the wound healing segment was the highest contributor to the hyperbaric oxygen therapy industry in 2021.
- By end user, the others segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
- By region, North America held the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Airox Technologies Limited
- Environmental Tectonics Corporation (Etc)
- Fink Engineering Pty Ltd.
- Gulf Coast Hyperbarics Inc.
- Haux-Life-Support GmbH
- Hearmec Co
- Hipertech Electronics Inc.
- Hyperbaric Modular Systems, Inc.
- Hyperbaric Sac
- Pan-America Hyperbarics Inc.
- Perry Baromedical Corporation
- Richmond Hyperbaric Health Centre Inc.
- Royal Ihc
- Sechrist Industries, Inc.
- Sos Group
- Tekna Hyperbaric Chambers
- Unique Group Fzc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 286 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 275.1 million |
| Forecasted Market Value ( USD | $ 457.64 million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
